The frequency of longitudinally extensive transverse myelitis in MS: A population-based study

Amezcua, 2013, Spinal cord lesions and disability in Hispanics with multiple sclerosis, J. Neurol., 260, 2770, 10.1007/s00415-013-7054-4

Banwell, 2008, Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders, Neurology, 70, 344, 10.1212/01.wnl.0000284600.80782.d5

Ciron, 2019, Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: a retrospective multicentric study, Mult. Scler., 10.1177/1352458519849511

Cobo-Calvo, 2016, Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications, Mult. Scler., 22, 312, 10.1177/1352458515591071

Dubey, 2018, Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody, JAMA Neurol.

Flanagan, 2016, Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum, Ann. Neurol., 10.1002/ana.24617

Flanagan, 2015, Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders, JAMA Neurol., 72, 81, 10.1001/jamaneurol.2014.2137

Flanagan, 2017, Myelitis in neuromyelitis optica spectrum disorder: the long and the short of it, Mult. Scler., 23, 360, 10.1177/1352458517692888

Jitprapaikulsan, 2018, Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis, Ophthalmology, 10.1016/j.ophtha.2018.03.041

Jitprapaikulsan, 2018, Novel glial targets and recurrent longitudinally extensive transverse myelitis, JAMA Neurol., 75, 892, 10.1001/jamaneurol.2018.0805

Matsuoka, 2007, Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese, Brain, 130, 1206, 10.1093/brain/awm027

Tartaglino, 1995, Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters, Radiology, 195, 725, 10.1148/radiology.195.3.7754002

Wu, 2008, Characterisation of the spectrum of demyelinating disease in Western Australia, J. Neurol. Neurosurg. Psychiatry, 79, 1022, 10.1136/jnnp.2007.131177